About us

Deep science.
Built for the field.

Mother Earth Dermatics is a Munich-based research and biotechnology company translating molecular insight into practical, sustainable insect control.

Farmer with cattle in BrazilEstablished 2017 · Munich

Our origin

Built around a question farmers already knew the answer to.

Conventional insecticides can be fast, familiar and affordable at the point of application—yet their long-term costs arrive through resistance, residues, withdrawal periods and ecological damage.

MED was founded to build a different category: scientifically rigorous repellents that are non-lethal, scalable and operationally easy to adopt. MED 017 is the platform behind that ambition.

01

Scientific honesty

We distinguish demonstrated evidence from active evaluation and future potential.

02

Practical adoption

Innovation matters only when it fits the realities of farms, distributors and regulators.

03

Ecological continuity

Protection should preserve the systems production ultimately depends on.

Leadership

Science, operations
and execution.

The founding team combines molecular science, intellectual property, product development and market delivery.

Elias Kassab01

Elias Kassab

Founder & CEO

Elias holds a PhD in biochemistry and molecular biology from the Technical University of Munich. Over eight years, he has led MED from scientific concept to regulatory-approved, commercially active products across IP, regulatory strategy, commercial development and investor relations.

Samer Younes02

Samer Younes

Founder & COO

Samer’s training in biochemistry and molecular biology underpins his operational leadership of MED’s core R&D and IP development. He holds a PhD from TUM, has authored 16 peer-reviewed publications and holds a foundational patent family.

Dania Awad03

Dania Awad

Founder & CTO

Dania’s expertise spans synthetic biotechnology, systems biology, material science and laboratory automation. A Franz Effenberger Postdoctoral Fellow, she also serves as a Group Leader at TUM, connecting molecular design with performance and manufacturability.

Advisors

Perspective from industry builders.

Dr. Leon Broers

Dr. Leon Broers

Former board and executive member of KWS SAAT.

Dr. Axel Heinemann

Dr. Axel Heinemann

Former BCG partner and serial entrepreneur.